TM2D1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.422600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.861200E-01
Normal-vs-Stage2
7.623000E-01
Normal-vs-Stage3
3.897800E-01
Normal-vs-Stage4
3.328000E-01
Stage1-vs-Stage2
7.733800E-01
Stage1-vs-Stage3
1.729440E-01
Stage1-vs-Stage4
1.969190E-01
Stage2-vs-Stage3
1.684580E-01
Stage2-vs-Stage4
3.537600E-01
Stage3-vs-Stage4
8.634300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.405400E-01
Normal-vs-AfricanAmerican
7.607800E-01
Normal-vs-Asian
8.494800E-01
Caucasian-vs-AfricanAmerican
4.115800E-01
Caucasian-vs-Asian
9.021000E-01
AfricanAmerican-vs-Asian
6.053600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.346000E-01
Normal-vs-Female
6.315000E-01
Male-vs-Female
2.836200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.953400E-01
Normal-vs-Age(41-60Yrs)
2.846200E-01
Normal-vs-Age(61-80Yrs)
9.526400E-01
Normal-vs-Age(81-100Yrs)
6.664400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.181600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.743800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.458800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.355230E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.003700E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.489400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.772800E-01
Normal-vs-Daily Drinker
8.984400E-01
Normal-vs-Weekly Drinker
6.209200E-01
Normal-vs-Occasional Drinker
2.179600E-01
Normal-vs-Social Drinker
8.477400E-01
Non Drinker-vs-Daily Drinker
5.493000E-01
Non Drinker-vs-Weekly Drinker
5.423200E-01
Non Drinker-vs-Occasional Drinker
3.481000E-03
Non Drinker-vs-Social Drinker
5.386600E-01
Daily Drinker-vs-Weekly Drinker
2.730600E-01
Daily Drinker-vs-Occasional Drinker
2.058400E-02
Daily Drinker-vs-Social Drinker
9.697400E-01
Weekly Drinker-vs-Occasional Drinker
4.081200E-03
Weekly Drinker-vs-Social Drinker
2.274600E-01
Occasional Drinker-vs-Social Drinker
2.568400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.421400E-01
Normal-vs-Grade 2
3.277500E-02
Normal-vs-Grade 3
7.194400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.107900E-02
Grade 1-vs-Grade 3
1.789970E-01
Grade 1-vs-Grade 4
2.421400E-01
Grade 2-vs-Grade 3
7.898200E-01
Grade 2-vs-Grade 4
3.277500E-02
Grade 3-vs-Grade 4
7.194400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.772000E-01
Normal-vs-NonDiabetic
7.153200E-01
Diabetic-vs-NonDiabetic
1.064230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.258800E-01
Normal-vs-NoPancreatitis
7.791200E-01
Pancreatitis-vs-NoPancreatitis
8.680800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.594800E-01
Normal-vs-N1
7.649600E-01
N0-vs-N1
9.718000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.334800E-01
Normal-vs-TP53-NonMutant
8.930800E-01
TP53-Mutant-vs-TP53-NonMutant
2.519800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
